O-101 XYOTAX™/carboplatin vs paclitaxel/carboplatin for the treatmentof PS2 patients with chemotherapy-naïve advanced non-small cell lung cancer (NSCLC): The stellar 3 phase III study
暂无分享,去创建一个
M. Socinski | K. O'Byrne | A. Szczesna | C. Langer | M. Šmakal | M. Dediu | S. Orlov | H. Ross